
X-COR Therapeutics Inc Profile last edited on: 11/6/2023
CAGE: 86X62
UEI: C8ALEDEUU658
Business Identifier: Novel extracorporeal carbon dioxide removal device Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 05
County: Middlesex
Congr. District: 05
County: Middlesex
Public Profile
A medical device company, X-COR Therapeutics management describe what the firm is about as their creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2021 | 1 | NIH | $293,121 | |
Project Title: Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure. |
Key People / Management
Brian Yale Chang
Jayon Wang
Jayon Wang
Company News
There are no news available.